GlassScriptPhysician profile
Scott M Haufe
NPI 1740235027
$2,430.73
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $550 · 2021: $694 · 2022: $141 · 2023: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $753.03 | 2019-2020 | |
| Nevro Corp. | $351.26 | 2019-2022 | |
| Medtronic, INC. | $224.93 | 2021-2023 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Nalu Medical, INC. | $201.74 | 2021 | |
| Pfizer INC. | $194.03 | 2019-2021 | |
| Boston Scientific Corporation | $128.95 | 2019 | |
| Collegium Pharmaceutical, INC. | $127.25 | 2020-2023 | Xtampza |
| Flowonix Medical Incorporated | $101.89 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $96.84 | 2020-2021 | |
| Abbott Laboratories | $45.25 | 2020 | |
| Shionogi INC | $32.27 | 2019 | |
| Redhill Biopharma INC. | $28.49 | 2021 | |
| Valinor Pharma, LLC | $20.75 | 2023 | Movantik |
| Eisai INC. | $20.10 | 2021 | |
| Indivior INC. | $19.68 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $19.45 | 2020 | |
| Grt US Holding, INC. | $19.35 | 2020 | |
| Ibsa Pharma INC. | $16.11 | 2021 | |
| Tersera Therapeutics LLC | $15.29 | 2019 | |
| Relievant Medsystems, INC. | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Haufe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.